These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 10616557

  • 21. The use of antibodies against the IL-2 receptor in transplantation.
    Waldmann TA, O'Shea J.
    Curr Opin Immunol; 1998 Oct; 10(5):507-12. PubMed ID: 9794841
    [Abstract] [Full Text] [Related]

  • 22. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
    Burke GW, Ciancio C, Blomberg BB, Rosen A, Suzart K, Roth D, Kupin W, Esquenazi V, Miller J.
    Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
    [No Abstract] [Full Text] [Related]

  • 23. The role of anti-IL-2 receptor in high-risk kidney transplant patients.
    Jirasiritham S, Sumethkul V, Mavichak V, Lertsithichai P, Jirasiritham S.
    Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764
    [Abstract] [Full Text] [Related]

  • 24. Daclizumab in live donor renal transplantation.
    Iverson AJ, Vick SC, Sarnacki CT, Wright FH.
    Transplant Proc; 2000 Jun; 32(4):790-2. PubMed ID: 10856587
    [No Abstract] [Full Text] [Related]

  • 25. Clinical advances in therapies targeting the interleukin-2 receptor.
    Church AC.
    QJM; 2003 Feb; 96(2):91-102. PubMed ID: 12589007
    [No Abstract] [Full Text] [Related]

  • 26. Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
    Waldmann TA.
    J Clin Immunol; 2007 Jan; 27(1):1-18. PubMed ID: 17216565
    [Abstract] [Full Text] [Related]

  • 27. IL-2 antibody induction and the outcome of pediatric renal transplants.
    Garcia CD, Barros VR, Schneider L, Alves MD, Silveira CG, Garcia VD.
    Transplant Proc; 2002 Nov; 34(7):2914-5. PubMed ID: 12431655
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Daclizumab to prevent acute rejection in renal transplantation.
    Abramowicz D.
    N Engl J Med; 1998 Jun 04; 338(23):1700-1. PubMed ID: 9616069
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.
    Vincenti F, Ramos E, Brattstrom C, Cho S, Ekberg H, Grinyo J, Johnson R, Kuypers D, Stuart F, Khanna A, Navarro M, Nashan B.
    Transplantation; 2001 May 15; 71(9):1282-7. PubMed ID: 11397963
    [Abstract] [Full Text] [Related]

  • 36. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB, Mendoza TR, Esmeraldo RM, Oliveira ML, Paes FJ, Silva Junior GB, Daher EF.
    Int Immunopharmacol; 2011 Nov 15; 11(11):1832-6. PubMed ID: 21835269
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Use of basiliximab and daclizumab in kidney transplantation.
    Olyaei AJ, Thi K, deMattos AM, Bennett WM.
    Prog Transplant; 2001 Mar 15; 11(1):33-7; quiz 38-9. PubMed ID: 11357555
    [Abstract] [Full Text] [Related]

  • 40. IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipients.
    Baan CC, Balk AH, van der Plas AJ, van Gelder T, Vantrimpont PJ, Maat LP, Weimar W.
    Transplant Proc; 2002 Dec 15; 34(8):3243-5. PubMed ID: 12493434
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.